Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Daniel Verina"'
Autor:
Adolfo Aleman, Morgan van Kesteren, Ariel Kogan Zajdman, Komal Srivastava, Christian Cognigni, Jacob Mischka, Lucia Y. Chen, Bhaskar Upadhyaya, Kseniya Serebryakova, Jessica R. Nardulli, Neko Lyttle, Katerina Kappes, Hayley Jackson, Charles R. Gleason, Annika Oostenink, Gianna Y. Cai, Oliver Van Oekelen, Harm van Bakel, Emilia Mia Sordillo, Carlos Cordon-Cardo, Miriam Merad, Sundar Jagannath, Ania Wajnberg, Viviana Simon, Samir Parekh, Hala Alshammary, Dalles Andre, Radhika Banu, Katherine Beach, María Carolina Bermúdez-González, Ajai Chari, Yuexing Chen, Hearn Cho, Adolfo Firpo, Ana Silvia Gonzalez-Reiche, Eun Hye Kim, Giulio Kleiner, Florian Krammer, Jacob Mauldin, Rao Mendu, Brian Monahan, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adrianna Rossi, Ashley Salimbangon, Laryssa Sanchez, Daniel Verina
Publikováno v:
EBioMedicine, Vol 98, Iss , Pp 104886- (2023)
Summary: Background: The real-world impact of bivalent vaccines for wild type (WA.1) and Omicron variant (BA.5) is largely unknown in immunocompromised patients with Multiple Myeloma (MM). We characterize the humoral and cellular immune responses in
Externí odkaz:
https://doaj.org/article/cc58fda45a4f4326af1b2763e037bc22
Autor:
Muhammad Elnaggar, Sarita Agte, Paula Restrepo, Meghana Ram, David Melnekoff, Christos Adamopoulos, Mark M. Stevens, Katerina Kappes, Violetta Leshchenko, Daniel Verina, Sundar Jagannath, Poulikos I. Poulikakos, Samir Parekh, Alessandro Laganà
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-8 (2022)
Abstract Background Multiple Myeloma (MM) is a progressive plasma cell neoplasm characterized by heterogeneous clonal expansion. Despite promising response rates achieved with anti-BCMA CAR-T cell therapy, patients may still relapse and there are cur
Externí odkaz:
https://doaj.org/article/a3c2b11498894e8198542cac2a5829ac
Autor:
Muhammad Elnaggar, Sarita Agte, Paula Restrepo, Meghana Ram, David Melnekoff, Christos Adamopoulos, Mark M. Stevens, Katerina Kappes, Violetta Leshchenko, Daniel Verina, Sundar Jagannath, Poulikos I. Poulikakos, Samir Parekh, Alessandro Laganà
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/79a65f21cdc143f391619c2b0d650826
Autor:
Larysa Sanchez, Joshua Richter, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Shambavi Richard, Lowena Tam, Daniel Verina, Ajai Chari
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
Daratumumab, a human immunoglobulin G1 kappa monoclonal antibody that targets CD38, is currently approved as monotherapy and in varying combinations with approved anti-myeloma regimens in both newly diagnosed multiple myeloma and relapsed refractory
Externí odkaz:
https://doaj.org/article/f0d2ae2c53d94f1dac01e92186e550a8
Autor:
Ajai Chari, Hearn J. Cho, Amishi Dhadwal, Gillian Morgan, Lisa La, Katarzyna Zarychta, Donna Catamero, Erika Florendo, Nadege Stevens, Daniel Verina, Elaine Chan, Violetta Leshchenko, Alessandro Laganà, Deepak Perumal, Anna Huo-Chang Mei, Kaity Tung, Jami Fukui, Sundar Jagannath, Samir Parekh
Publikováno v:
Blood Advances, Vol 1, Iss 19, Pp 1575-1583 (2017)
Abstract: Phase 3 studies combining histone deacetylase inhibitors with bortezomib were hampered by gastrointestinal (GI) intolerance, which was not observed when combined with immunomodulatory drugs. This study is a single-center phase 2 study of pa
Externí odkaz:
https://doaj.org/article/c6d9e6ac5c2e415ea1de9942843d0af4
Publikováno v:
The Journal for Nurse Practitioners. 18:693-698
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cf9420e9682771116bde374d259f555
https://doi.org/10.1016/j.nurpra.2022.05.001
https://doi.org/10.1016/j.nurpra.2022.05.001
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 13:7-14
Multiple myeloma (MM) is an incurable plasma cell disorder that affects nearly 35,000 people annually. Over 149,000 individuals are estimated to live in the United States with MM. Research has generated a greater understanding of the pathology of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a883122628ffb95f4e95c21df25c36e
https://doi.org/10.6004/jadpro.2022.13.5.10
https://doi.org/10.6004/jadpro.2022.13.5.10
Autor:
Shambavi Richard, Guido Lancman, Santiago Thibaud, Ajai Chari, Samir Parekh, Adriana Rossi, Hearn J. Cho, Larysa Sanchez, Joshua Richter, Cesar Rodriguez, Elizabeth Aronson, Karen Louw, Kiah Purcell, Daniel Verina, Juliet Escalon, Sundar Jagannath
Publikováno v:
Blood. 140:7444-7446
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c25ba352f07233cbb5fcedf2e17a3625
https://doi.org/10.1182/blood-2022-170404
https://doi.org/10.1182/blood-2022-170404
Autor:
Shambavi Richard, Guido Lancman, Adriana Rossi, Ajai Chari, Samir Parekh, Larysa Sanchez, Cesar Rodriguez, Hearn J. Cho, Joshua Richter, Santiago Thibaud, Kiah Purcell, Elizabeth Aronson, Daniel Verina, Juliet Escalon, Karen Louw, Sundar Jagannath
Publikováno v:
Blood. 140:4301-4302
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1c9a427e091cbaaabe6b68f516f5518
https://doi.org/10.1182/blood-2022-170119
https://doi.org/10.1182/blood-2022-170119
Autor:
Deepu Madduri, Ajai Chari, Daniel Verina, Samir Parekh, Hearn Jay Cho, Lowena Tam, Shambavi Richard, Sundar Jagannath, Joshua Richter, Larysa Sanchez
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
Therapeutic Advances in Hematology
Therapeutic Advances in Hematology
Daratumumab, a human immunoglobulin G1 kappa monoclonal antibody that targets CD38, is currently approved as monotherapy and in varying combinations with approved anti-myeloma regimens in both newly diagnosed multiple myeloma and relapsed refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1474701309bb29439a63194b79e951f1
https://doaj.org/article/f0d2ae2c53d94f1dac01e92186e550a8
https://doaj.org/article/f0d2ae2c53d94f1dac01e92186e550a8